Okusa M D, Velázquez H, Wright F S
Department of Medicine, Yale University School of Medicine, New Haven 06510.
Am J Physiol. 1991 Mar;260(3 Pt 2):F459-65. doi: 10.1152/ajprenal.1991.260.3.F459.
In previous studies the effectiveness of amiloride (AML) in reducing K secretion has been variable. Based on studies by Cuthbert and Wong (Mol. Pharmacol. 8: 222-229, 1972) in which the Na-channel-blocking action of AML in frog skin was found to require the availability of Ca ions in extracellular fluid, we postulated that the ability of AML and its analogue, benzamil (BZA), to inhibit distal tubule K secretion depends on the presence of Ca in luminal fluid. We found that addition of Ca to a perfusion solution containing 50 microM BZA did reduce K secretion more than BZA alone. Maximal inhibition was observed with 2.5 mM free ionic Ca. Graded increases in luminal Ca in presence of AML or BZA reduced K transport in a dose-dependent manner. The decrease in K secretion with increasing luminal Ca was paralleled by a decrease in transepithelial voltage. These results support our hypothesis that the effectiveness of Na-channel blockers to reduce K secretion by the rat distal tubule depends on presence of luminal Ca and suggest an interaction between luminal Ca and Na-channel blockers on the Na channel.
在以往的研究中,氨氯吡咪(AML)减少钾分泌的效果存在差异。基于Cuthbert和Wong(《分子药理学》8:222 - 229,1972年)的研究,他们发现在青蛙皮肤中,AML的钠通道阻断作用需要细胞外液中钙离子的存在,我们推测AML及其类似物苯扎咪(BZA)抑制远端肾小管钾分泌的能力取决于管腔液中钙的存在。我们发现,向含有50微摩尔BZA的灌注溶液中添加钙,确实比单独使用BZA更能减少钾分泌。在游离离子钙浓度为2.5毫摩尔时观察到最大抑制作用。在存在AML或BZA的情况下,管腔钙的分级增加以剂量依赖的方式减少钾转运。随着管腔钙增加钾分泌减少的同时,跨上皮电压也降低。这些结果支持了我们的假设,即钠通道阻滞剂减少大鼠远端肾小管钾分泌的效果取决于管腔钙的存在,并提示管腔钙与钠通道阻滞剂在钠通道上存在相互作用。